Skip to main content
NIH funding notice PA-21-232

Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (R01 Clinical Trial Optional)

Closed on September 7, 2024.

Posted
May 26, 2021
Close date
September 7, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,420,358 in first-year total cost, median $710,179.

Most frequent study sections

  1. Biobehavioral Medicine and Health Outcomes Study Section[BMHO]1
  2. Healthcare and Health Disparities Study Section[HHD]1

Most frequent institutions

  1. STANFORD UNIVERSITY1
  2. UNIVERSITY OF CHICAGO1
Competing awards under PA-21-232 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Implementing Scalable, PAtient-centered Team-based Care for Adults with Type 2 Diabetes and Health Disparities (iPATH)1R01MD017870-01A1SINGER, SARA JEANSTANFORD UNIVERSITY, CA$781,919HHD
2023ARISE (Achieving Routine Intervention and Screening for Emotional health)1R01DK133603-01A1BAIG, ARSHIYA AHMEDHESSLER, DANIELLE MARIEUNIVERSITY OF CHICAGO, IL$638,439BMHO

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PA-21-232: Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (R01 Clinical Trial Optional) | ScienceDex | ConductScience